23andme semaglutide The Research Institute has just published a new study in the scientific journal Nature about genetics and GLP-1s! , The new study of 27,000+ participants from 23andMe identified DNA variants As a medical school professor,

Prof Adam Taylor, from Lancaster University, said potential benefits in pre-clinical studies such as those in animals and cells do not necessarily mean a peptide is beneficial for humans

DOI: Published online: October 15, 2025 1 Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan 2 Division of Endocrinology and Metabolism, Department of Internal Medicine, Kurume University School of Medicine, Kurume, Japan 3 Kurinami Clinic, Kanzaki, Kumamoto, Japan 4 Division of Cardiovascular Medicine, Diabetes Care Center, Jinnouchi Hospital, Kumamoto, Japan 5 Division of Preventive Cardiology, Department of Cardiovascular Medicine, Kumamoto University Hospital, Kumamoto, Japan Corresponding author: Hideaki Jinnouchi

Genetic Predispositions in Peptide Metabolic Pathways Individual responses to GLP-1 peptides vary significantly

It is well-established that eicosanoids produced by the COX-2 and 5-LOX pathways contribute to the progression of colon cancer

The oral Wegovy drug showed roughly similar weight loss and side effects in clinical trials as the shot, according to Novo Nordisk

Is it safe to take GLP-1 continuously for years